David J Browning
Overview
Explore the profile of David J Browning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
2252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shanmugam S, Browning D
Clin Ophthalmol
. 2024 Nov;
18:3239-3247.
PMID: 39555212
Purpose: Compare large language models (LLMs) in analyzing and responding to a difficult series of ophthalmic cases. Design: A comparative case series involving LLMs that met inclusion criteria tested on...
2.
Groothoff J, Browning D
Am J Ophthalmol
. 2024 Oct;
270():245-251.
PMID: 39369930
Purpose: To discuss the history and current state of private equity in ophthalmology, and to explore potential implications for ophthalmology practices, physicians, and patients. Design: Perspective. Methods: Selected articles in...
3.
Browning D
Clin Ophthalmol
. 2024 Sep;
18:2539-2544.
PMID: 39257592
Purpose: To highlight gaps in the professional ethics of ophthalmology. Design: Perspective. Methods: Presentation of problematic cases in ophthalmologic ethics with juxtaposition of ethical, legal, and conscientious viewpoints informed by...
4.
Browning D, Ong S, Clarkson J, Huang H
Am J Ophthalmol
. 2024 Feb;
262:19-24.
PMID: 38341168
Purpose: To review changes in the provision of charity eye care in the past 50 years with hypothesized resulting effects on surgical training and patient outcomes. Design: Perspective. Methods: Case...
5.
Rush R, Rush S, Reinauer R, Gomez Bastar P, Browning D
Retina
. 2022 Mar;
42(7):1292-1301.
PMID: 35263314
Purpose: To report updated clinical outcomes in subjects undergoing pars plana vitrectomy (PPV) using modern techniques and equipment for the treatment of proliferative diabetic retinopathy-related complications. Pooled analysis of five...
6.
Poor S, Weissgerber G, Adams C, Bhatt H, Browning D, Chastain J, et al.
Am J Ophthalmol
. 2022 Mar;
239:180-189.
PMID: 35247334
Purpose: To evaluate whether topical acrizanib (LHA510), a small-molecule vascular endothelial growth factor receptor inhibitor, could suppress the need for anti-vascular endothelial growth factor therapy over a 12-week period in...
7.
Ozawa H, Ueno S, Ohno-Tanaka A, Sakai T, Hashiguchi M, Shimizu M, et al.
Jpn J Ophthalmol
. 2021 May;
65(4):472-481.
PMID: 34014447
Purpose: To describe the characteristics of Japanese patients with hydroxychloroquine (HCQ) retinopathy developing within 3 years of treatment outset. Study Design: Retrospective case series METHODS: Three patients with HCQ retinopathy...
8.
Browning D, Greenberg P
Clin Ophthalmol
. 2021 Apr;
15:1403-1408.
PMID: 33854294
Purpose: To quantify the economic incentives associated with the choice of anti-VEGF drugs for retinal diseases. Methods: An economic model was created based on the distribution of use and number...
9.
Browning D, Yokogawa N, Greenberg P, Perlman E
Am J Ophthalmol
. 2020 Nov;
222:400-401.
PMID: 33228963
No abstract available.
10.
Rosenfeld P, Browning D
Am J Ophthalmol
. 2020 Nov;
223:446-447.
PMID: 33187630
No abstract available.